During the past decade, Intermountain Healthcare Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Intermountain Healthcare Research" are "Adenovirus Infection" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Intermountain Healthcare Research" in a lesser frequency.

Most popular intervention types in "Intermountain Healthcare Research" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brincidofovir" (1 trials) and "RNS System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intermountain Healthcare Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Intermountain Healthcare Research". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Intermountain Healthcare Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intermountain Healthcare Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".